ArticleDocumenta ophthalmologica. Advances in ophthalmology2026
Disease progression in IMPDH1 gene-associated rod-cone dystrophy caused by a rare p.Thr244Pro heterozygous variant.
Article in Documenta ophthalmologica. Advances in ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeA hallmark of the IMPDH1-related rod-cone dystrophy is the highly variable expressivity. Disease onset, severity and progression are variant-dependent due to specific affected photoreceptor mechanisms, underscoring the importance of genotype-phenotype correlations. We provide a detailed clinical characterization of a patient with rod-cone dystrophy caused by a rare de novo missense IMPDH1 variant. CASE DESCRIPTION: A 33-year-old female patient was assessed over a period of four years following the onset of her symptoms. A multimodal evaluation of both structural and functional aspects, along with molecular analysis, was performed. We identified a rare de novo missense variant in the IMPDH1 gene (NM_000883.4:c.730A > C, p.Thr244Pro), which had been previously reported in one patient. Threonine 244 is located at the interface between the catalytic domain and the regulatory Bateman domain. This region is crucial for GDP/GTP nucleotide binding and mediates feedback regulation, putatively influencing allosteric regulation. The SD-OCT imaging revealed a symmetrically preserved ellipsoid zone in the central retina, alongside noticeable neuroretinal layer loss beyond the temporal vascular arcades. Functional examinations showed normal BCVA, microperimetric macular thresholds, and color vision thresholds in both eyes. Multifocal ERG was slightly reduced, and full-field ERGs were affected in both dark- and light-adapted responses, consistent with the peripheral sensitivity loss in the 80° automated visual field. No significant changes were observed throughout the follow-up period.
conclusionsThe IMPDH1 p.Thr244Pro variant was associated with preserved central retina structure and function with stable peripheral dysfunction in the fourth decade of life, suggesting a relatively stationary disease course that starkly contrasts the rapid progression of retinal dystrophies caused by other IMPDH1 variants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.